Lyell Immunopharma Gestione
Gestione criteri di controllo 3/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Lynn Seely
Amministratore delegato
US$2.6m
Compenso totale
| Percentuale dello stipendio del CEO | 24.6% |
| Mandato del CEO | 1.9yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 2.3yrs |
| Durata media del Consiglio di amministrazione | 4.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Lyell Immunopharma: Oversold And Poised For A Turning Point To Growth
Oct 25Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalysts
Apr 16Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
Feb 23
Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
Nov 09Analysts' Revenue Estimates For Lyell Immunopharma, Inc. (NASDAQ:LYEL) Are Surging Higher
Aug 29We Think Lyell Immunopharma (NASDAQ:LYEL) Can Afford To Drive Business Growth
Aug 11Lyell Immunopharma (NASDAQ:LYEL) Is In A Good Position To Deliver On Growth Plans
Dec 15Lyell Immunopharma gets FDA nod to start phase 1 trial of its cancer therapy LYL845
Oct 06Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
Sep 12News Flash: Analysts Just Made A Huge Upgrade To Their Lyell Immunopharma, Inc. (NASDAQ:LYEL) Forecasts
Aug 08Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
Apr 29We Think Lyell Immunopharma (NASDAQ:LYEL) Can Afford To Drive Business Growth
Dec 31Here's Why We're Not Too Worried About Lyell Immunopharma's (NASDAQ:LYEL) Cash Burn Situation
Sep 17Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$204m |
| Jun 30 2024 | n/a | n/a | -US$210m |
| Mar 31 2024 | n/a | n/a | -US$228m |
| Dec 31 2023 | US$3m | US$650k | -US$235m |
| Sep 30 2023 | n/a | n/a | -US$190m |
| Jun 30 2023 | n/a | n/a | -US$209m |
| Mar 31 2023 | n/a | n/a | -US$182m |
| Dec 31 2022 | US$19m | US$30k | -US$183m |
| Sep 30 2022 | n/a | n/a | -US$258m |
| Jun 30 2022 | n/a | n/a | -US$237m |
| Mar 31 2022 | n/a | n/a | -US$263m |
| Dec 31 2021 | US$5m | n/a | -US$250m |
Compensazione vs Mercato: La retribuzione totale di Lynn ($USD 2.65M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.47M ).
Compensazione vs guadagni: La retribuzione di Lynn è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Lynn Seely (65 yo)
1.9yrs
Mandato
US$2,647,476
Compensazione
Dr. Lynn Seely, MD, Ph D., serves as Lead Independent Director at Blueprint Medicines Corporation since June 2021. She serves as President and Chief Executive Officer at Lyell Immunopharma, Inc. since Dece...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder & Executive Chairman | 4.8yrs | US$310.75k | 1.4% $ 4.0m | |
| President | 1.9yrs | US$2.65m | Nessun dato | |
| Chief Financial Officer | 3.8yrs | US$4.32m | 0.0031% $ 9.0k | |
| Chief Operating Officer | 3yrs | US$3.11m | 0.0032% $ 9.2k | |
| Chief Scientific Officer | 2.8yrs | US$2.23m | 0.0046% $ 13.1k | |
| Chief Business Officer | 1.3yrs | US$4.26m | Nessun dato | |
| Founder & Scientific Advisor | 2.3yrs | Nessun dato | Nessun dato | |
| Founder & Scientific Advisor | 2.3yrs | Nessun dato | Nessun dato | |
| Director of Accounting | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Communications & Investor Relations | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Human Resources | 1.3yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Clinical Development Operations | 1.3yrs | Nessun dato | Nessun dato |
2.3yrs
Durata media
54yo
Età media
Gestione esperta: Il team dirigenziale di LYEL è considerato esperto (durata media dell'incarico 2.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder & Executive Chairman | 4.8yrs | US$310.75k | 1.4% $ 4.0m | |
| President | 3.5yrs | US$2.65m | Nessun dato | |
| Independent Director | 6.2yrs | US$286.75k | 0% $ 0 | |
| Independent Director | 4.5yrs | US$301.75k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$290.75k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$293.25k | 0% $ 0 | |
| Director | less than a year | Nessun dato | Nessun dato | |
| Lead Independent Director | 6.3yrs | US$330.25k | 0.12% $ 346.5k | |
| Independent Director | 6.3yrs | US$285.75k | 1.68% $ 4.8m |
4.5yrs
Durata media
64yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di LYEL sono considerati esperti (durata media dell'incarico 4.5 anni).